Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Early Hum Dev. 2018 Mar 23;119:68–72. doi: 10.1016/j.earlhumdev.2018.02.010

Table 1.

Clinical characteristics of the cohort.

Variable Cohort (N = 44)
Maternal characteristics
Ethnicity Caucasian: 23 (52.3%), Black: 21 (47.7%)
Maternal age < 20 years: 7 (15.9%), > 20 years: 37 (84.1%)
Illicit drug use None: 40 (91%), at least one: 4 (9%)
Marital status Married: 17 (38.6%), Single: 27 (61.4%)
Insurance Private: 20 (45.5%), Public: 24 (54.5%)
Birth weight in grams (mean ± sd) 856 ( ± 280)
Gestational age (mean ± sd) 26 ( ± 2)
PMA at study (mean ± sd) 39 ( ± 2)
SGA status, n (%) 6 (13.6%)
Antenatal steroids, n (%) 29 (66%)
CRIB-II score (mean ± sd) 11 ( ± 3)
NEC surgery, n (%) 7 (15.9%)
PDA ligation, n (%) 6 (13.6%)
ROP surgery, n (%) 13 (29.5%)
Post-natal steroids, n (%) 15 (34.1%)
Oxygen therapy at 36 wk., n (%) 34 (77.3%)
Inotropes, n (%) 21 (47.7%)
IVH grade 3–4, n (%) 19 (43.2%)
Moderate/severe injury on MRI at TEA, n (%) 25 (56.8%)
Motor delay, n (%) 27 (61%)
Language delay, n (%) 23 (52%)
Cognitive delay, n (%) 24 (54%)

PMA: Post-menstrual age, SGA: Small for gestational age, CRIB-II score: clinical risk index for babies score, NEC: necrotizing enterocolitis, PDA: Patent ductus arteriosus, ROP: retinopathy of prematurity, IVH: Intraventricular hemorrhage, diagnosed by cranial ultrasound.